Es sind 2+ Publikationen für dieses Produkt verfügbar. Der Kaninchen Polyklonal anti-Vaccinia Virus Antikörper wird verwendet zum Nachweis von Vaccinia Virus in Proben von Vaccinia Virus (VACV). Er wurde validiert für ELISA, IHC und WB.
Optimal conditions should be determined byt he investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Konzentration
Lot specific
Buffer
Purified by ammonium sulphate precipitation and supplied in PBS buffer with 0.1 % NaN3.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Handhabung
Avoid repeated freeze/thaw cycles. Dilute only prior to immediate use.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
Perino, Thielens, Crouch, Spehner, Crance, Favier: "Protective effect of surfactant protein d in pulmonary vaccinia virus infection: implication of A27 viral protein." in: Viruses, Vol. 5, Issue 3, pp. 928-53, (2013) (PubMed).
Johnson, Ovsyannikova, Madden, Poland, Muddiman: "Accurate mass precursor ion data and tandem mass spectrometry identify a class I human leukocyte antigen A*0201-presented peptide originating from vaccinia virus." in: Journal of the American Society for Mass Spectrometry, Vol. 16, Issue 11, pp. 1812-7, (2005) (PubMed).
Target
Vaccinia Virus (VACV)
(Vaccina Virus (VACV))
Andere Bezeichnung
Vaccinia Virus
Substanzklasse
Virus
Hintergrund
Vaccinia virus (VACV or VV) is a large, complex, enveloped virus belonging to the poxvirus family. It has a linear, double-stranded DNA genome approximately 190 kbp in length, and which encodes for approximately 250 genes. The dimensions of the virion are roughly 360 × 270 × 250 nm, with a mass of approximately 5-10 fg. Vaccinia virus is well-known for its role as a vaccine that eradicated the smallpox disease, making it the first human disease to be successfully eradicated by science.